MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$1,006,000
EPS
-$0.59
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
0 3,000 0 0
Research and development
427,000 362,000 469,000 185,000
General and administrative
585,000 548,000 718,000 854,000
Total operating expenses
1,012,000 910,000 1,187,000 1,039,000
Loss from operations
-1,012,000 -907,000 -1,187,000 -1,039,000
Change in fair value of warrant liability
NaN 0 0 31,000
Other income, net
6,000 14,000 28,000 19,000
Other income (expense), net
NaN 14,000 28,000 -12,000
Net loss
-1,006,000 -893,000 -1,159,000 -1,051,000
Basic EPS
-0.59 -0.383 -0.55 -0.63
Diluted EPS
-0.59 -0.383 -0.55 -0.63
Basic Average Shares
1,948,357 2,332,792 2,183,039 1,676,345
Diluted Average Shares
1,948,357 2,332,792 2,183,039 1,676,345
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$1,006,000 (6.24%↑ Y/Y)Other income, net$6,000 (-68.42%↓ Y/Y)Loss from operations-$1,012,000 (7.33%↑ Y/Y)Total operatingexpenses$1,012,000 (-7.50%↓ Y/Y)General andadministrative$585,000 (-21.69%↓ Y/Y)Research and development$427,000 (23.05%↑ Y/Y)

Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics, Inc. (TCRT)